Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086
2006
Breast cancer cell differentiation by WEB-2086
publication
Evidence: moderate
Author Information
Author(s): Cellai C, Laurenzana A, Vannucchi A M, Caporale R, Paglierani M, Di Lollo S, Pancrazzi A, Paoletti F
Primary Institution: University of Florence
Hypothesis
Can WEB-2086 induce growth inhibition and differentiation in human breast cancer cells?
Conclusion
WEB-2086 effectively inhibits growth and induces differentiation in breast cancer cells.
Supporting Evidence
- WEB-2086 inhibited proliferation in various solid tumor cell lines.
- MCF-7 and MDA-MB-231 cells showed significant growth arrest when treated with WEB-2086.
- WEB-2086 induced morphological changes typical of mature mammary cells.
- Treatment with WEB-2086 increased neutral lipid accumulation in breast cancer cells.
Takeaway
WEB-2086 is a drug that helps stop breast cancer cells from growing and helps them become more like normal cells.
Methodology
The study involved treating breast cancer cell lines with WEB-2086 and analyzing their growth and differentiation through various assays.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website